Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Laboratorios SALVAT S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Laboratorios SALVAT S.A. - Product Pipeline Review - 2014', provides an overview of the Laboratorios SALVAT S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios SALVAT S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Laboratorios SALVAT S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Laboratorios SALVAT S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Laboratorios SALVAT S.A.'s pipeline products Reasons to buy - Evaluate Laboratorios SALVAT S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Laboratorios SALVAT S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Laboratorios SALVAT S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Laboratorios SALVAT S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios SALVAT S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Laboratorios SALVAT S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Laboratorios SALVAT S.A. Snapshot 4 Laboratorios SALVAT S.A. Overview 4 Key Information 4 Key Facts 4 Laboratorios SALVAT S.A.- Research and Development Overview 5 Key Therapeutic Areas 5 Laboratorios SALVAT S.A.- Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products- Monotherapy 8 Pipeline Products- Combination Treatment Modalities 9 Laboratorios SALVAT S.A.- Pipeline Products Glance 10 Laboratorios SALVAT S.A.- Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 Laboratorios SALVAT S.A.- Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Laboratorios SALVAT S.A.- Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Laboratorios SALVAT S.A.- Drug Profiles 13 (fluocinolone acetonide + ciprofloxacin hydrochloride) 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 G-238 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 tarafenacin 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Stem Cell Therapy for Bone Regeneration 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Laboratorios SALVAT S.A.- Pipeline Analysis 18 Laboratorios SALVAT S.A.- Pipeline Products by Target 18 Laboratorios SALVAT S.A.- Pipeline Products by Route of Administration 19 Laboratorios SALVAT S.A.- Pipeline Products by Molecule Type 20 Laboratorios SALVAT S.A.- Pipeline Products by Mechanism of Action 21 Laboratorios SALVAT S.A.- Recent Pipeline Updates 22 Laboratorios SALVAT S.A.- Dormant Projects 23 Laboratorios SALVAT S.A.- Locations And Subsidiaries 24 Head Office 24 Other Locations & Subsidiaries 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables Laboratorios SALVAT S.A., Key Information 4 Laboratorios SALVAT S.A., Key Facts 4 Laboratorios SALVAT S.A.- Pipeline by Indication, 2014 6 Laboratorios SALVAT S.A.- Pipeline by Stage of Development, 2014 7 Laboratorios SALVAT S.A.- Monotherapy Products in Pipeline, 2014 8 Laboratorios SALVAT S.A.- Combination Treatment Modalities in Pipeline, 2014 9 Laboratorios SALVAT S.A.- Phase III, 2014 10 Laboratorios SALVAT S.A.- Phase II, 2014 11 Laboratorios SALVAT S.A.- Preclinical, 2014 12 Laboratorios SALVAT S.A.- Pipeline by Target, 2014 18 Laboratorios SALVAT S.A.- Pipeline by Route of Administration, 2014 19 Laboratorios SALVAT S.A.- Pipeline by Molecule Type, 2014 20 Laboratorios SALVAT S.A.- Pipeline Products by Mechanism of Action, 2014 21 Laboratorios SALVAT S.A.- Recent Pipeline Updates, 2014 22 Laboratorios SALVAT S.A.- Dormant Developmental Projects,2014 23 Laboratorios SALVAT S.A., Subsidiaries 24
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.